SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001615774-17-002211
Filing Date
2017-05-11
Accepted
2017-05-11 10:14:59
Documents
55
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q s106117_10q.htm 10-Q 257703
2 EXHIBIT 31.1 s106117_ex31-1.htm EX-31.1 10196
3 EXHIBIT 32.1 s106117_ex32-1.htm EX-32.1 4474
  Complete submission text file 0001615774-17-002211.txt   3094622

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE bthe-20170331.xml EX-101.INS 617819
5 XBRL SCHEMA FILE bthe-20170331.xsd EX-101.SCH 36599
6 XBRL CALCULATION FILE bthe-20170331_cal.xml EX-101.CAL 45609
7 XBRL DEFINITION FILE bthe-20170331_def.xml EX-101.DEF 153947
8 XBRL LABEL FILE bthe-20170331_lab.xml EX-101.LAB 300651
9 XBRL PRESENTATION FILE bthe-20170331_pre.xml EX-101.PRE 228704
Mailing Address 354 MERRIMACK STREET #4 LAWRENCE MA 01843
Business Address 354 MERRIMACK STREET #4 LAWRENCE MA 01843 (603) 935-9799
Boston Therapeutics, Inc. (Filer) CIK: 0001473579 (see all company filings)

IRS No.: 270801073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54586 | Film No.: 17832809
SIC: 2834 Pharmaceutical Preparations